Cite
HARVARD Citation
Lund, A. et al. (2018). Comprehensive long‐term efficacy and safety of recombinant human alpha‐mannosidase (velmanase alfa) treatment in patients with alpha‐mannosidosis. Journal of inherited metabolic disease. 41 (6), pp. 1225-1233. [Online].